Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Рекомендации по диагностике и лечению артериальной гипертонии 2008: что нового? - Журнал Системные Гипертензии №3 (2008)
Рекомендации по диагностике и лечению артериальной гипертонии 2008: что нового?
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Диагностика и лечение артериальной гипертензии. Проект Российских рекомендаций. Кардиоваск. тер. и проф. 2008; 4. Прил.
2. ESH-ESC Guidelines Committee. 2007 guidelines for the management of arterial hypertension. J Hypertension 2007; 25: 1105–87.
3. The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782–8.
4. PROGRESS Collaborative Study Group. Randomised trial of perindopril based blood pressure-lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–41.
5. ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358 (15): 1547–59.
6. Aksnes TA, Flaa A, Strand A, Kjeldsen SE. Prevention of new–onset atrial fibrillation and its predictors with angiotensin II–receptor blockers in the treatment of hypertension and heart failure. J Hypertens 2007; 25: 15–23.
7. Healey JS, Baranchuk A, Crystal E et al. prevention of atrial fibrillation with angiotensin–converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005; 45: 1832–9.
8. Lithell H, Hansson L, Skoog I et al. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE). Principal results of a randomised double-blind intervention trial. J Hypertens 2003; 21: 875–86.
9. Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J 1995; 108 (9): 710–17.
10. Beckett NS, Peters R, Fletcher AE et al; the HYVET Study Group. Treatment of Hypertension in Patients 80 Years of Age or Older. N Engl J Med 2008; 358 (18): 1887–98.
2. ESH-ESC Guidelines Committee. 2007 guidelines for the management of arterial hypertension. J Hypertension 2007; 25: 1105–87.
3. The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782–8.
4. PROGRESS Collaborative Study Group. Randomised trial of perindopril based blood pressure-lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033–41.
5. ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358 (15): 1547–59.
6. Aksnes TA, Flaa A, Strand A, Kjeldsen SE. Prevention of new–onset atrial fibrillation and its predictors with angiotensin II–receptor blockers in the treatment of hypertension and heart failure. J Hypertens 2007; 25: 15–23.
7. Healey JS, Baranchuk A, Crystal E et al. prevention of atrial fibrillation with angiotensin–converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005; 45: 1832–9.
8. Lithell H, Hansson L, Skoog I et al. SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE). Principal results of a randomised double-blind intervention trial. J Hypertens 2003; 21: 875–86.
9. Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J 1995; 108 (9): 710–17.
10. Beckett NS, Peters R, Fletcher AE et al; the HYVET Study Group. Treatment of Hypertension in Patients 80 Years of Age or Older. N Engl J Med 2008; 358 (18): 1887–98.
Авторы
И.Е.Чазова, Л.Г.Ратова
РК НПК Росмедтехнологий, Москва
РК НПК Росмедтехнологий, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.